Abeona Therapeutics Inc Ret. on assets
What is the Ret. on assets of Abeona Therapeutics Inc?
The Ret. on assets of Abeona Therapeutics Inc is -62.08%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Abeona Therapeutics Inc
What does Abeona Therapeutics Inc do?
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Companies with ret. on assets similar to Abeona Therapeutics Inc
- Bion Plc Ord Npv has Ret. on assets of -62.16%
- Spielvereinigung Unterhaching FuSball GmbH & Co. KGaA has Ret. on assets of -62.15%
- Churchill Capital Corp IV has Ret. on assets of -62.15%
- ContextLogic Inc has Ret. on assets of -62.15%
- Mercurity Fintech Inc has Ret. on assets of -62.10%
- Upland Resources has Ret. on assets of -62.09%
- Abeona Therapeutics Inc has Ret. on assets of -62.08%
- Minerva Neurosciences Inc has Ret. on assets of -62.07%
- Asia Television has Ret. on assets of -62.04%
- Melodyvr Plc has Ret. on assets of -62.04%
- AMCO United has Ret. on assets of -61.90%
- PharmaCielo has Ret. on assets of -61.82%
- Solar Alliance has Ret. on assets of -61.81%